CytoDyn Inc. (CYDY) financial statements (2022 and earlier)

Company profile

Business Address 1111 MAIN STREET, SUITE 660
VANCOUVER, WA 98660
State of Incorp. DE
Fiscal Year End May 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,875 14,2822,6131,2311,776
Cash and cash equivalents8,875 14,2822,6131,2311,776
Restricted cash and investments  10854  
Receivables225     
Inventory, net of allowances, customer advances and progress billings88,557     
Inventory88,557     
Prepaid expense2,979 498107227207
Other undisclosed current assets1,174 22,0371,7961,8624,138
Total current assets:101,810 36,8275,3693,3216,121
Noncurrent Assets
Operating lease, right-of-use asset617 176
Property, plant and equipment119 55291117
Intangible assets, net (including goodwill)1,153 13,45615,4751,5671,917
Intangible assets, net (excluding goodwill)1,153 13,45615,4751,5671,917
Total noncurrent assets:1,889 13,68715,5051,5781,935
TOTAL ASSETS:103,699 50,51420,8744,8998,055
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities65,955 37,61918,04116,6004,281
Accounts payable58,008 29,47916,23915,8424,281
Accrued liabilities    58 
Employee-related liabilities796 6,8661,589700 
Interest and dividends payable7,151 1,274213  
Debt43,947  3,586 1,059
Estimated litigation liability1,401     
Other liabilities4,457     
Other undisclosed current liabilities149 6,8825,300134804
Total current liabilities:115,909 44,50126,92616,7336,144
Noncurrent Liabilities
Long-term debt and lease obligation486 8,494455  
Long-term debt, excluding current maturities  8,431455  
Operating lease, liability486 63
Liabilities, other than long-term debt   2,4071,3243,015
Derivative instruments and hedges, liabilities   2,4071,3243,015
Other undisclosed noncurrent liabilities(486) (63)   
Total noncurrent liabilities:486 8,4942,8621,3243,015
Total liabilities:116,395 52,99529,78818,0579,159
Stockholders' equity
Stockholders' equity attributable to parent, including:(12,696) (2,480)(8,914)(13,158)(1,103)
Preferred stock    00
Common stock686 519330217149
Treasury stock, value  (0)(0)(0) 
Additional paid in capital589,971 351,711220,120159,765121,737
Accumulated deficit(603,353) (354,711)(229,363)(173,139)(122,990)
Other undisclosed stockholders' equity attributable to parent  00  
Total stockholders' equity:(12,696) (2,480)(8,914)(13,158)(1,103)
TOTAL LIABILITIES AND EQUITY:103,699 50,51420,8744,8998,055

Income statement (P&L) ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
Revenues266 500   
Other income  500   
Cost of revenue
(Cost of Goods and Services Sold)
(53)     
Gross profit:213 500   
Operating expenses(47,172) (74,647)(55,852)(45,919)(27,331)
Operating loss:(46,959) (74,147)(55,852)(45,919)(27,331)
Nonoperating income
(Investment Income, Nonoperating)
  51,6711,6952,180
Interest and debt expense(8,088) (18,220)(4,832)(5,925)(613)
Loss from continuing operations before equity method investments, income taxes:(55,047) (92,362)(59,014)(50,150)(25,764)
Other undisclosed loss from continuing operations before income taxes(12,496) (32,042)   
Loss from continuing operations before income taxes:(67,543) (124,403)(59,014)(50,150)(25,764)
Income tax benefit   2,827  
Net loss available to common stockholders, diluted:(67,543) (124,403)(56,187)(50,150)(25,764)

Comprehensive Income ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
Net loss:(67,543) (124,403)(56,187)(50,150)(25,764)
Comprehensive loss, net of tax, attributable to parent:(67,543) (124,403)(56,187)(50,150)(25,764)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: